Is recombinant human TSH as effective as thyroid hormone withdrawal in the detection and treatment of metastatic differentiated thyroid cancer?

Expert Review of Endocrinology and Metabolism

Volumn 7, Issue 6, 2012, Pages 633-635

  Lervasi, Giorgio ^a   Bottoni, Antonio ^a   Filidei, Elena ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

124I PET; 131I WB; differentiated thyroid cancer; metastasis detection; recombinant human TSH; thyroid hormone withdrawal

Indexed keywords

IODINE 124; IODINE 131; LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROID HORMONE;

ARTICLE; CANCER DIAGNOSIS; CANCER THERAPY; DIFFERENTIATED THYROID CANCER; HUMAN; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT WITHDRAWAL; WHOLE BODY IMAGING;

EID: 84869821756     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/eem.12.52     Document Type: Article

References (6)

1. Mallick U, Harmer C, Yap B et al. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N. Engl. J. Med. 366(18), 1674-1685 (2012).
2. Zanotti-Fregonara P, Hindié E. On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer. Eur. J. Nucl. Med. Mol. Imaging 37(12), 2264-2266 (2010).
3. Van Nostrand D, Khorjekar GR, O'Neil J et al. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET. J. Nucl. Med. 53(3), 359-362 (2012).
4. Rosario PW, Salles DS, Purisch S. Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): possible implications for tumor growth. Arq. Bras. Endocrinol. Metabol. 53(6), 767-770 (2009).
5. Tala H, Robbins R, Fagin JA, Larson SM, Tuttle RM. Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH. J. Clin. Endocrinol. Metab. 96(7), 2105-2111 (2011).
6. Hugo J, Robenshtok E, Grewal R, Larson S, Tuttle RM. Recombinant human thyroid stimulating hormoneassisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence. Thyroid 22(10), 1007-1015 (2012).